DocuSign, Inc. (DOCU) Earnings Call Transcripts

49 earnings calls from January 2020 to June 4, 2026

NasdaqGS US Information Technology Software

DocuSign, Inc.'s Latest Earnings Call - Q1 FY2027

DocuSign reported its Q1 fiscal 2027 earnings with revenue of $830 million, marking a 9% year-over-year increase, and an operating margin of 32%. The company highlighted the growing adoption of its AI-native Intelligent Agreement Management (IAM) platform, which now represents 12.6% of total ARR. Management reiterated its fiscal 2027 guidance, expecting revenue between $3.490 billion to $3.502 billion, reflecting a 9% YoY increase. The company also raised its operating margin guidance slightly, reflecting confidence in its ongoing transformation and growth trajectory.

Reported metrics

MetricValueContext
Revenue $830 million (inline) vs $830 million expected, +9% YoY
Operating Margin 32% (beat) vs 29.5% last year, +2.5 percentage points
Free Cash Flow $289 million (beat) 35% margin, up from 30% last year
Non-GAAP EPS $1.09 (beat) vs $0.90 last year, +21% YoY
ARR 12.6% from IAM (positive) up from 10.8% last quarter

Guidance from management

DocuSign maintained its fiscal 2027 guidance, expecting revenue between $3.490 billion to $3.502 billion, and ARR growth of 8.5% YoY. Operating margin guidance was slightly raised to 30.5% to 31.0%.

What management said

No, I don't think we're going to start that. But I mean I think as we've shared with you in the past, overall, IAM is very significantly accretive relative to the baseline trend for those customers. And then as part of that, it's amplifying the consumption of signing. Now there are many ways in which IAM delivers value. So it makes it easier to design more workflows that can trigger more signs. It may add more feat...
— Allan Thygesen, Q1 FY2027 earnings call
Yes. Let me just comment on the ACV metric, and then Blake, you can jump in as well. Look, I think Docusign has a expanding opportunity to go deeper with customers because of IAM. And I think that the fact that we're growing the number of 300,000 customers is just, I think, a nice numerical indicator of that opportunity. And I think we hope there should be more to come as we go forward.
— Allan Thygesen, Q1 FY2027 earnings call

What analysts pressed on

Analysts expressed concerns about the pace of IAM adoption and its impact on revenue growth. Questions focused on the competitive landscape, particularly against CLM vendors, and the company's ability to maintain growth momentum in a challenging macro environment.

Main topics on the call

Read the full DocuSign, Inc. transcript (Q1 FY2027) → Summary generated from the call transcript; every figure above is stated by management on the record.

About DocuSign, Inc.

DocuSign, Inc. (DOCU) is a publicly listed company in the Software industry, within the Information Technology sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 49 calls on record spanning January 15, 2020 to June 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 49 DocuSign, Inc. earnings call transcripts on record, spanning January 15, 2020 to June 4, 2026. Based on this history, DocuSign, Inc. reports quarterly. The most recent call on file is dated June 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
DOCU
Exchange
NasdaqGS
Country
US
Sector
Information Technology
Industry
Software
Calls on record
49
First call
January 15, 2020
Most recent
June 4, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Jun 4, 2026 Read transcript
Q4 FY2026 Mar 17, 2026 Read transcript
Company Conference Presentations Dec 10, 2025 Read transcript
Q3 FY2026 Dec 4, 2025 Read transcript
Q2 FY2026 Sep 4, 2025 Read transcript
Special Calls Apr 16, 2025 Read transcript
Q4 FY2025 Mar 13, 2025 Read transcript
Q3 FY2025 Dec 5, 2024 Read transcript
Q2 FY2025 Sep 5, 2024 Read transcript
Q1 FY2025 Jun 6, 2024 Read transcript
Q4 FY2024 Mar 7, 2024 Read transcript
Q3 FY2024 Dec 7, 2023 Read transcript
Q2 FY2024 Sep 7, 2023 Read transcript
Q1 FY2024 Jun 8, 2023 Read transcript
Q4 FY2023 Mar 9, 2023 Read transcript
Company Conference Presentations Jan 9, 2023 Read transcript
Q3 FY2023 Dec 8, 2022 Read transcript
Q1 FY2023 Jun 9, 2022 Read transcript
Q4 FY2022 Mar 10, 2022 Read transcript
Company Conference Presentations Jan 10, 2022 Read transcript
Company Conference Presentations Dec 8, 2021 Read transcript
Q3 FY2022 Dec 2, 2021 Read transcript
Company Conference Presentations Sep 14, 2021 Read transcript
Company Conference Presentations Sep 13, 2021 Read transcript
Company Conference Presentations Sep 13, 2021 Read transcript
Company Conference Presentations Sep 8, 2021 Read transcript
Q2 FY2022 Sep 2, 2021 Read transcript
Company Conference Presentations Jun 10, 2021 Read transcript
Company Conference Presentations Jun 9, 2021 Read transcript
Company Conference Presentations Jun 7, 2021 Read transcript
Q1 FY2022 Jun 3, 2021 Read transcript
Analyst/Investor Day Mar 24, 2021 Read transcript
Q4 FY2021 Mar 11, 2021 Read transcript
Company Conference Presentations Mar 1, 2021 Read transcript
Company Conference Presentations Jan 11, 2021 Read transcript
Company Conference Presentations Dec 7, 2020 Read transcript
Q3 FY2021 Dec 3, 2020 Read transcript
Company Conference Presentations Sep 15, 2020 Read transcript
Company Conference Presentations Sep 14, 2020 Read transcript
Company Conference Presentations Sep 10, 2020 Read transcript
Company Conference Presentations Sep 9, 2020 Read transcript
Q2 FY2021 Sep 3, 2020 Read transcript
Company Conference Presentations Jul 21, 2020 Read transcript
Company Conference Presentations Jun 10, 2020 Read transcript
Q1 FY2021 Jun 4, 2020 Read transcript
Q4 FY2020 Mar 12, 2020 Read transcript
Company Conference Presentations Mar 2, 2020 Read transcript
Company Conference Presentations Feb 24, 2020 Read transcript
Company Conference Presentations Jan 15, 2020 Read transcript